Press Releases April 28, 2026 04:15 PM

Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

Lumexa Imaging schedules Q1 2026 earnings release and conference call for May 12, 2026

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
LMRI

Lumexa Imaging, a leading US outpatient imaging services provider, announced it will release its Q1 2026 financial and operational results after market close on May 12, 2026, followed by a conference call and webcast to discuss the results.

Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
LMRI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Lumexa Imaging operates over 185 outpatient imaging centers across 13 states, conducting approximately 4 million outpatient procedures in 2025.
  • The earnings release and conference call provide transparency on financial and operational performance for investors.
  • Lumexa Imaging focuses on delivering clinical excellence and advanced imaging technology in partnership with health systems and radiologists.

RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET.

The live audio webcast will be available in the Investor Relations section of the Company’s website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year.

About Lumexa Imaging

Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team members and more than 185 outpatient imaging centers across 13 states, our team conducted approximately 4 million outpatient procedures system-wide in 2025. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.

Media Contact
Melissa Weston
[email protected]

IR Contact
Sue Dooley
[email protected]

        


Risks

  • Financial results could show weaker performance impacting stock price.
  • Operational challenges or regulatory changes in healthcare could affect future growth.
  • Competitive pressures in the outpatient imaging sector could impact market share and margins.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026